Arbutus Biopharma ABUS
NASDAQ ABUS
$3.88 +0.15 (+4.17%)
As of: Nov 10, 2026 · 1:02 PM EST

Arbutus Biopharma (ABUS) Finished Goods (2010)

Updated

Arbutus Biopharma (ABUS) posted Finished Goods of $148,752 for Q4 2010.

Analysis

Arbutus Biopharma (ABUS) Finished Goods (2010) Analysis & Trends

At the end of FY2010, Arbutus Biopharma's Finished Goods came in at $146,378.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Arbutus Biopharma 755.33 Mn 382.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 150,791.32
API Access

Arbutus Biopharma Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=ABUS&period=max&api_key=YOUR_API_KEY